Valuation Indivior Pharmaceuticals, Inc. London S.E.

Stocks

Delayed London S.E. 16:35:04 24/07/2025 BST			5-day change	1st Jan Change
1,238.00 ^GBX	+1.56%		+5.27%	+20.90%

08-03	Indivior Pharmaceuticals, Inc. Enters into Senior Secured Term Loan Facility	CI
08-03	Indivior Pharmaceuticals, Inc. Proposes Special Cash Dividend	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,423	2,969	2,085	1,553	4,480	4,228	-	-
Change	-	22.54%	-29.76%	-25.5%	188.39%	-5.62%	-	-
Enterprise Value (EV) ¹	1,563	2,435	2,008	1,567	4,604	4,215	3,658	3,037
Change	-	55.81%	-17.52%	-21.95%	193.72%	-8.44%	-13.23%	-16.97%
P/E	12.8x	-57.2x	1,527x	-34.5x	21.9x	9.63x	8.73x	7.98x
PBR	-	59.3x	-	-8.02x	-45.8x	-	-	-
PEG	-	0x	-15x	0x	-0x	0x	0.8x	0.85x
Capitalization / Revenue	3.06x	3.29x	1.91x	1.31x	3.62x	3.17x	3.02x	2.84x
EV / Revenue	1.98x	2.7x	1.84x	1.32x	3.72x	3.16x	2.61x	2.04x
EV / EBITDA	7.74x	10.8x	6.97x	4.64x	10.8x	5.79x	4.63x	3.53x
EV / EBIT	8.36x	11.5x	7.47x	5.02x	11.1x	6.12x	4.96x	3.82x
EV / FCF	4.61x	-10.7x	-4.86x	-196x	-49.5x	8.28x	6.72x	4.92x
FCF Yield	21.7%	-9.32%	-20.6%	-0.51%	-2.02%	12.1%	14.9%	20.3%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	1.35	-0.38	0.01	-0.36	1.64	3.72	4.105	4.49
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	791	901	1,093	1,188	1,239	1,332	1,400	1,489
EBITDA ¹	202	225	288	338	428	728.4	790.8	859.6
EBIT ¹	187	212	269	312	415	688.8	737.7	795.7
Net income ¹	205	-53	2	-48	210	474.3	530	582.9
Net Debt ¹	-860	-534	-77	14	124	-12.5	-570	-1,191
Reference price ²	17.25	21.75	15.27	12.43	35.88	35.82	35.82	35.82
Nbr of stocks (in thousands)	140,437	136,489	136,551	124,970	124,854	118,014	-	-
Announcement Date	16/02/22	16/02/23	22/02/24	20/02/25	26/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ELI LILLY AND COMPANY	33.86x	12.29x	24.9x	0.58%	1,060B
JOHNSON & JOHNSON	30.03x	-	-	1.99%	651B
ABBVIE INC.	33.56x	7.77x	16.15x	2.61%	465B
ROCHE HOLDING AG	20.52x	4.87x	12.06x	2.71%	365B
NOVARTIS AG	22.43x	5.77x	14.31x	2.77%	300B
ASTRAZENECA PLC	21.39x	4.38x	12.52x	2.01%	258B
AMGEN INC.	27.85x	7.18x	12.75x	2.29%	238B
NOVO NORDISK A/S	13.86x	4.91x	10.27x	3.71%	210B
GILEAD SCIENCES, INC.	-45.25x	6.53x	25.49x	2.23%	184B
Average	17.58x	6.71x	16.06x	2.32%	414.49B
Weighted average by Cap.	24.66x	8.19x	18.09x	1.93%